F M Debruyne - Concepedia

Author

F M Debruyne

Also Known As

F M Debruyne, F. M. J. (a) Debruyne, F.M.H. Debruyne, F.M.J. (b) Debruyne, F.M.J. Debruyne, FMJ DEBRUYNE, FMJ Debruyne, Frans M. J. Debruyne, Frans M.J. Debruyne

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen

About

F M Debruyne is an author at Radboud University Nijmegen specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.6K
2	Pathology	4	4	608
3	Cell Biology	3	3	1.3K
4	Health Sciences	1	1	18
5	Immunology	1	1	26

F M Debruyne

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Rainy Umbas, Jack A. Schalken, T W Aalders, PubMed UrologyDevelopmental BiologyHuman Prostate CancerMedicineCell Adhesion	1992	611
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Rainy Umbas, William B. Isaacs, P P Bringuier, PubMed UrologyProstate CapsuleGenitourinary CancerMedicineRadical Prostatectomy	1994	535
Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Yahya Tamimi, H.G. Van Der Poel, M M Denyn, PubMed Tumor BiologyChromatinUrologyGenitourinary CancerMedicine	1993	133
The Effects of Treatment of Urinary Incontinence in General Practice A.L.M. Lagro‐Janssen, F M Debruyne, AJA SMITS, Family Practice Control GroupUrologyGeneral PractitionerVoiding DysfunctionUrinary Incontinence	1992	122
Original Articles P. D. J. Vegt, J.A. Witjes, Wim P.J. Witjes, The Journal of Urology Urological ResearchUrologySurgical OncologyGenitourinary CancerMedicine	1995	90
Research in 'Prostatitis Syndromes':The Use of Alfuzosin (a New α(1)-Receptor-Blocking Agent) in Patients Mainly Presenting with Micturition Complaints of an Irritative Nature and Confirmed Urodynamic Abnormalities Jean J. de la Rosette, Herbert F.M. Karthaus, Philip E.V. van Kerrebroeck, European Urology	1992	65
Comparison of P53 protein overexpression with P53 mutation in bladder cancer: clinical and biologic aspects. Jacqueline A. M. Vet, P P Bringuier, H. Ewout Schaafsma, PubMed	1995	56
Value of Biochemical Markers in the Management of Disseminated Prostatic Cancer Peter F.A. Mulders, A.G.M. Theeuwes, G.O.N. Oosterhof, European Urology Biomarker (Medicine)UrologyBiochemical MarkersGenitourinary CancerMedicine	1992	29
Conventional bladder wash cytology performed by four experts versus quantitative image analysis. H.G. Van Der Poel, M. E. Boon, P. Van Stratum, PubMed	1997	28
Immunohistochemical analysis of tumor antigen saturation following injection of monoclonal antibody G250. Martijn G. Steffens, Jeannette Oosterwijk‐Wakka, N.E.M. Zegwaart-Hagemeier, PubMed Immunocytochemical TechniqueImmunologyPathologyImmunotherapeuticsMonoclonal Antibody G250	1999	26

Page 1